57 related articles for article (PubMed ID: 16624971)
1. Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
Aharoni R; Kayhan B; Brenner O; Domev H; Labunskay G; Arnon R
J Pharmacol Exp Ther; 2006 Jul; 318(1):68-78. PubMed ID: 16624971
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications.
Arnon R; Aharoni R
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14593-8. PubMed ID: 15371592
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of glatiramer acetate treatment on syndecan-1 expression in dextran sodium sulfate colitis.
Yablecovitch D; Shabat-Simon M; Aharoni R; Eilam R; Brenner O; Arnon R
J Pharmacol Exp Ther; 2011 May; 337(2):391-9. PubMed ID: 21310817
[TBL] [Abstract][Full Text] [Related]
4. Topiramate in the treatment of neuropathic pain in patients with cancer.
Bendaly EA; Jordan CA; Staehler SS; Rushing DA
Support Cancer Ther; 2007 Sep; 4(4):241-6. PubMed ID: 18632523
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive efficacy of lacosamide in rat models for tumor- and chemotherapy-induced cancer pain.
Beyreuther BK; Callizot N; Brot MD; Feldman R; Bain SC; Stöhr T
Eur J Pharmacol; 2007 Jun; 565(1-3):98-104. PubMed ID: 17395176
[TBL] [Abstract][Full Text] [Related]
6. Impact of Disease-Modifying Therapies on Gut-Brain Axis in Multiple Sclerosis.
Del Negro I; Pez S; Versace S; Marziali A; Gigli GL; Tereshko Y; Valente M
Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38276041
[TBL] [Abstract][Full Text] [Related]
7. Protective Effects of Glatiramer Acetate Against Paclitaxel-Induced Peripheral Neuropathy in Rats: A Role for Inflammatory Cytokines and Oxidative Stress.
Dekamin S; Ghasemi M; Dehpour AR; Ghazi-Khansari M; Shafaroodi H
Neurochem Res; 2024 Apr; 49(4):1049-1060. PubMed ID: 38252396
[TBL] [Abstract][Full Text] [Related]
8. Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders.
Brummer T; Ruck T; Meuth SG; Zipp F; Bittner S
Ther Adv Neurol Disord; 2021; 14():17562864211035542. PubMed ID: 34457039
[TBL] [Abstract][Full Text] [Related]
9. Can FDA-Approved Immunomodulatory Drugs be Repurposed/Repositioned to Alleviate Chronic Pain?
Inyang KE; Folger JK; Laumet G
J Neuroimmune Pharmacol; 2021 Sep; 16(3):531-547. PubMed ID: 34041656
[TBL] [Abstract][Full Text] [Related]
10. Randomized peptide assemblies for enhancing immune responses to nanomaterials.
Votaw NL; Collier L; Curvino EJ; Wu Y; Fries CN; Ojeda MT; Collier JH
Biomaterials; 2021 Jun; 273():120825. PubMed ID: 33901731
[TBL] [Abstract][Full Text] [Related]
11. The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5.
Radomir L; Kramer MP; Perpinial M; Schottlender N; Rabani S; David K; Wiener A; Lewinsky H; Becker-Herman S; Aharoni R; Milo R; Mauri C; Shachar I
Nat Commun; 2021 Mar; 12(1):1893. PubMed ID: 33767202
[TBL] [Abstract][Full Text] [Related]
12. Induction or aggravation of other immune-mediated disorders by disease-modifying therapy in treatment of multiple sclerosis.
Baghbanian SM; Sahraian MA
Iran J Neurol; 2018 Jul; 17(3):129-136. PubMed ID: 30886680
[TBL] [Abstract][Full Text] [Related]
13. Co-Stimulation-Impaired Bone Marrow-Derived Dendritic Cells Prevent Dextran Sodium Sulfate-Induced Colitis in Mice.
Engman C; Garciafigueroa Y; Phillips BE; Trucco M; Giannoukakis N
Front Immunol; 2018; 9():894. PubMed ID: 29774025
[TBL] [Abstract][Full Text] [Related]
14. Genomic correlates of glatiramer acetate adverse cardiovascular effects lead to a novel locus mediating coronary risk.
Brænne I; Zeng L; Willenborg C; Tragante V; Kessler T; ; ; Willer CJ; Laakso M; Wallentin L; Franks PW; Salomaa V; Dehghan A; Meitinger T; Samani NJ; Asselbergs FW; Erdmann J; Schunkert H
PLoS One; 2017; 12(8):e0182999. PubMed ID: 28829817
[TBL] [Abstract][Full Text] [Related]
15. Biomaterial strategies for generating therapeutic immune responses.
Kelly SH; Shores LS; Votaw NL; Collier JH
Adv Drug Deliv Rev; 2017 May; 114():3-18. PubMed ID: 28455189
[TBL] [Abstract][Full Text] [Related]
16. Selenium nanoparticles decorated with Ulva lactuca polysaccharide potentially attenuate colitis by inhibiting NF-κB mediated hyper inflammation.
Zhu C; Zhang S; Song C; Zhang Y; Ling Q; Hoffmann PR; Li J; Chen T; Zheng W; Huang Z
J Nanobiotechnology; 2017 Mar; 15(1):20. PubMed ID: 28270147
[TBL] [Abstract][Full Text] [Related]
17. Oral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice.
Shigemori S; Watanabe T; Kudoh K; Ihara M; Nigar S; Yamamoto Y; Suda Y; Sato T; Kitazawa H; Shimosato T
Microb Cell Fact; 2015 Nov; 14():189. PubMed ID: 26608030
[TBL] [Abstract][Full Text] [Related]
18. The effect of dexmedetomidine on inflammatory response of septic rats.
Zhang J; Wang Z; Wang Y; Zhou G; Li H
BMC Anesthesiol; 2015 May; 15():68. PubMed ID: 25929655
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota in multiple sclerosis: possible influence of immunomodulators.
Cantarel BL; Waubant E; Chehoud C; Kuczynski J; DeSantis TZ; Warrington J; Venkatesan A; Fraser CM; Mowry EM
J Investig Med; 2015 Jun; 63(5):729-34. PubMed ID: 25775034
[TBL] [Abstract][Full Text] [Related]
20. Soluble Syndecan-1 Levels Are Elevated in Patients with Inflammatory Bowel Disease.
Yablecovitch D; Stein A; Shabat-Simon M; Naftali T; Gabay G; Laish I; Oren A; Konikoff FM
Dig Dis Sci; 2015 Aug; 60(8):2419-26. PubMed ID: 25702042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
